InvestorsHub Logo
Followers 207
Posts 17343
Boards Moderated 2
Alias Born 01/12/2012

Re: sushifishman post# 22628

Sunday, 06/23/2019 1:08:58 PM

Sunday, June 23, 2019 1:08:58 PM

Post# of 43784
Very Nice Article , thankyou for taking the time to write that.

"If Multikine is successful for HNC, then it will be studied for many more types of cancer such as breast and cervical. The market potential is enormous.

We reiterate our $250 per share.

A buyout is always a possibility. Recent buyouts of similar bios have been in the $2B to $12B range, as noted above. Even at $2B, the share price would be about $50 a share...a multi-multi bagger."

CVM Long
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News